How I Sequence Therapy with Novel Agents in CTCL


The cutaneous T-cell lymphomas are a rare, heterogenous group of lymphomas that involve skin. Both because of their rarity, and the plethora of somewhat novel systemic treatment options, practitioners who do not have the opportunity to treat this patient population on a daily basis may be confused about how to select the most appropriate and efficacious drug for their patient. With a review of the medical literature, the speaker will delineate how to approach drug selection in different patient populations, including some personal recommendations both based on the literature and clinical experience.


  • Lauren Pinter-Brown


Member Type Price
List Price $30.00
Active, International, Emeritus, and Honorary Members $20.00
Associate, International Associate, Student, and Resident Members $20.00
back to top